Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
COVID-19, is enveloped virus and has the Spike (S) glycoprotein on the virion envelope …

As an enveloped virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
delivers its viral genome into host cells via fusion of the viral and cell membranes. Here, we …

Severe SARS-CoV-2 infection is complicated by dysregulation of the blood coagulation
system and high rates of thrombosis, but virus-intrinsic mechanisms underlying this …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic. Angiotensin-converting enzyme 2 (ACE2) is an entry receptor for SARS-CoV-2 …

Revealing the mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) entry and cell-to-cell spread might provide insights for understanding the underlying …

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, much effort has
been dedicated to identifying effective antivirals against severe acute respiratory syndrome …

Proprotein convertases activate various envelope glycoproteins and participate in cellular
entry of many viruses. We recently showed that the convertase furin is critical for the …

The ongoing global vaccination program to prevent SARS-CoV-2 infection, the causative
agent of COVID-19, has had significant success. However, recently, virus variants that can …

Since the end of 2019, COVID-19 has caused worldwide pandemic. SARS-CoV-2, the culprit
of this epidemic, binds to the host receptor Angiotensin converting enzyme 2 (ACE2) using …

Angiotensin converting enzyme 2 (ACE2) serves as the primary entry receptor for severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, ACE2-independent …